In the last trading session, 3.07 million Cns Pharmaceuticals Inc (NASDAQ:CNSP) shares changed hands as the company’s beta touched 1.07. With the company’s per share price at $0.11 changed hands at $0.0 or -0.09% during last session, the market valuation stood at $6.24M. CNSP’s last price was a discount, traded about -103990.91% off its 52-week high of $114.50. The share price had its 52-week low at $0.10, which suggests the last value was 9.09% up since then. When we look at Cns Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 9.47 million shares, with the 3-month average coming to 15.06 million.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Instantly CNSP was in red as seen at the end of in last trading. With action -10.05%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -99.82%, with the 5-day performance at -10.05% in the red. However, in the 30-day time frame, Cns Pharmaceuticals Inc (NASDAQ:CNSP) is 0.27% up. Looking at the short shares, we see there were 1.14 million shares sold at short interest cover period of 0.04 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target for the stock as assigned by Wall Street analysts is 0.5, meaning bulls need an upside of 78.0% from its current market value. According to analyst projections, CNSP’s forecast low is 0.5 with 0.5 as the target high. To hit the forecast high, the stock’s price needs a -354.55% plunge from its current level, while the stock would need to soar -354.55% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.98%.
CNSP Dividends
Cns Pharmaceuticals Inc is expected to release its next quarterly earnings report in January.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.04% of Cns Pharmaceuticals Inc shares while 0.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.80%.
